Neha Krishnamohan
Director/Board Member chez ARCUTIS BIOTHERAPEUTICS, INC.
Fortune : 55 565 $ au 31/03/2024
Profil
Neha Krishnamohan is an Independent Director at Arcutis Biotherapeutics, Inc. She previously worked as a Vice President-Healthcare Investment Banking at The Goldman Sachs Group, Inc. from 2015 to 2021.
She also served as the CFO & Executive VP-Corporate Development at Kinnate Biopharma, Inc. from 2021 to 2024.
Ms. Krishnamohan completed her undergraduate degree at Duke University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/05/2023 | 5 607 ( 0,00% ) | 55 565 $ | 31/03/2024 | |
KINNATE BIOPHARMA, INC.
-.--% | 03/04/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Neha Krishnamohan
| Sociétés | Poste | Début |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Director/Board Member | 02/09/2022 |
Anciens postes connus de Neha Krishnamohan
| Sociétés | Poste | Fin |
|---|---|---|
| KINNATE BIOPHARMA INC. | Director of Finance/CFO | 03/04/2024 |
| THE GOLDMAN SACHS GROUP, INC. | Corporate Officer/Principal | 01/05/2021 |
Formation de Neha Krishnamohan
| Duke University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| THE GOLDMAN SACHS GROUP, INC. | Finance |
| ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
